Britain's drug regulator said since the balance of risk is in favour of older people, the advice would be for younger people to be offered alternatives such as the Pfizer/BioNTech and Moderna vaccines
Coronavirus vaccine tracker: DCGI sends notice to Serum Institute for not halting Oxford clinical trials
AstraZeneca has paused global trials of the experimental COVID-19 vaccine after a UK participant had an adverse reaction to it
AstraZeneca's COVID-19 vaccine trial paused after 'potentially unexplained' adverse reaction in participant
In a statement issued on Tuesday evening, AstraZeneca said its "standard review process triggered a pause to vaccination to allow review of safety data"